Correlation Between Sarthak Metals and Beta Drugs
Can any of the company-specific risk be diversified away by investing in both Sarthak Metals and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarthak Metals and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarthak Metals Limited and Beta Drugs, you can compare the effects of market volatilities on Sarthak Metals and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarthak Metals with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarthak Metals and Beta Drugs.
Diversification Opportunities for Sarthak Metals and Beta Drugs
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sarthak and Beta is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Sarthak Metals Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Sarthak Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarthak Metals Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Sarthak Metals i.e., Sarthak Metals and Beta Drugs go up and down completely randomly.
Pair Corralation between Sarthak Metals and Beta Drugs
Assuming the 90 days trading horizon Sarthak Metals Limited is expected to under-perform the Beta Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Sarthak Metals Limited is 1.11 times less risky than Beta Drugs. The stock trades about -0.22 of its potential returns per unit of risk. The Beta Drugs is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 197,130 in Beta Drugs on September 2, 2024 and sell it today you would earn a total of 20,055 from holding Beta Drugs or generate 10.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Sarthak Metals Limited vs. Beta Drugs
Performance |
| Timeline |
| Sarthak Metals |
| Beta Drugs |
Sarthak Metals and Beta Drugs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarthak Metals and Beta Drugs
The main advantage of trading using opposite Sarthak Metals and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarthak Metals position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.| Sarthak Metals vs. Reliance Industries Limited | Sarthak Metals vs. Life Insurance | Sarthak Metals vs. Indian Oil | Sarthak Metals vs. Oil Natural Gas |
| Beta Drugs vs. Reliance Industries Limited | Beta Drugs vs. Tata Consultancy Services | Beta Drugs vs. HDFC Bank Limited | Beta Drugs vs. Bharti Airtel Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |